Summary
In 115 patients with pituitary macroadenomas, the findings on mid-field MRI were correlated with the hormonal activity of the tumours. Adenomas secreting growth hormone (GH), prolactin (PRL) and clinically nonsecretory adenomas were studied. Tumour size, invasiveness and signal intensity patterns were recorded. Relaxation times and ratios of signal intensity and proton density (relative to the corpus callosum) were analysed in areas of apparently solid tissue in a subgroup of 59 previously untreated patients. Invasiveness was more common in PRL-and GH-secreting adenomas than in the nonsecreting ones. Diffuse invasion of the base of the skull was most common in prolactinomas, and associated with a lower frequency of suprasellar tumour extension. In prolactinomas, a correlation was found between the maximum serum PRL level and tumour size. Haemorrhagic, cystic or necrotic areas were less common in GH-secreting tumours than in the other types. Haemorrhage was more common in prolactinomas than in nonsecreting tumours. MR parameters were similar in prolactinomas and nonsecreting adenomas, but indicated a smaller amount of water in GH-secreting tumours.
Similar content being viewed by others
References
Abboud CF, Laws ER Jr (1988) Diagnosis of pituitary tumors. Endocrinol Metab Clin North Am 17: 241–280
Scheithauer BW, Kovacs KT, Laws ER, Randall RV (1986) Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65: 733–744
Shaffi OM, Wrightson P (1975) Dural invasion by pituitary tumours. NZ Med J 81: 386–390
Wrightson P (1978) Conservative removal of small pituitary tumours: is it justified by the pathological findings? J Neurol Neurosurg Psychiatry 41: 283–289
Selman WR, Laws ER Jr, Scheithauer BW, Carpenter SM (1986) The occurrence of dural invasion in pituitary adenomas. J Neurosurg 64: 402–407
Lundberg PO, Drettner B, Hemmingsson A, Stenkvist B, Wide L (1977) The invasive pituitary adenoma. A prolactin-producing tumor. Arch Neurol 34: 742–749
Kaufman B, Kaufman BA, Arafah BM, Roessmann U, Selman WR (1987) Large pituitary gland adenomas evaluated with magnetic resonance imaging. Neurosurgery 21: 540–546
Lundin P, Bergström K, Thuomas K-Å, Lundberg PO, Muhr C (1991) Comparison of MR imaging and CT in pituitary macroadenomas. Acta Radiol 32: 189–196
Sartor K, Karnaze MG, Winthrop JD, Gado M, Hodges FJ (1987) MR imaging in infra-, para- and retrosellar mass lesions. Neuroradiology 29: 19–29
Scotti G, Yu CY, Dillon WP, Norman D, Colombo N, Newton TH, De Groot J, Wilson CB (1988) MR imaging of cavernous sinus involvement by pituitary adenomas. AJR 151: 799–806
Davis PC, Hoffman JC Jr, Tindall GT, Braun IF (1985) CT-surgical correlation in pituitary adenomas: evaluation in 113 patients. AJNR 6: 711–716
Hallenga B, Saeger W, Lüdecke DK (1988) Necrosis of prolactinsecreting pituitary adenomas under treatment with dopamine agonists: light microscopical and morphometric studies. Exp Clin Endocrinol 92: 59–68
Wakai S, Fukushima T, Teramoto A, Sano K (1981) Pituitary apoplexy: its incidence and clinical significance. J Neurosurg 55: 187–193
Mohr G, Hardy J (1982) Hemorrhage, necrosis and apoplexy in pituitary adenomas. Surg Neurol 18: 181–189
Mohanty S, Tandon PN, Bancrji AK, Prakash B (1977) Haemorrhage into pituitary adenomas. J Neurol Neurosurg Psychiatry 40: 987–991
Dooms GC, Uske A, Brant-Zawadzki M, Kucharczyk W, Lemme-Plaghos L, Newton TH, Norman D (1986) Spin-echo MR imaging of intracranial hemorrhage. Neuroradiology 28: 132–138
Jungreis CA, Chandra R, Kricheff I, Chuba JV (1988) In vitro magnetic resonance properties of CNS neoplasms and associated cysts. Invest Radiol 23: 12–16
Kjos BO, Brant-Zawadzki M, Kucharczyk W, Kelly WM, Norman D, Newton TH (1985) Cystic intracranial lesions: magnetic resonance imaging. Radiology 155: 363–369
Just M, Thelen M (1988) Tissue characterization with T1, T2 and proton density values: results in 160 patients with brain tumors. Radiology 169: 779–785
Lundberg PO, Muhr C, Bergström K, Thuomas K-Å, Hartvig P, Lundqvist H, Antoni G, Långström B (1986) PET and NMR in diagnosis of pituitary adenomas. In: Battistin L, Gerstenbrand F (eds) PET and NMR: new perspectives in neuroimaging and in clinical neurochemistry. Liss, New York, pp 407–424
Riedel M, Noldus J, Saeger W, Lüdecke DK (1986) Sellar lesions associated with isolated hyperprolactiemia. Morphological, immunocytochemical, hormonal and clinical results. Acta Endocrinol (Copenh) 113: 196–203
Virapongse C, Bhimani S, Sarwar M, Greenberg A, Kim J (1984) Prolactin-secreting pituitary adenomas. CT appearnce in diffuse invasion. Radiology 152: 447–451
Wilson CB (1984) A decade of pituitary microsurgery. J Neurosurg 61: 814–833
Ostrov SG, Quencer RM, Hoffman JC, Davis PC, Hasso AN, David NJ (1989) Hemorrhage within pituitary adenomas: how often associated with pituitary apoplexy syndrome? AJNR 10: 503–510
Kamman RL, Go KG, Brouwer W, Berendsen HJC (1988) Nuclear magnetic resonance relaxation in experimental brain edema: effects of water concentration, protein concentration, and temperature. Magn Reson Med 6: 265–274
Sperber GO, Ericsson A, Hemmingsson A, Jung B, Thuomas K-0A (1986) Improved formulae for signal amplitudes in repeated NMR sequences: application in NMR imaging. Magn Reson Med 3: 685–698
Shucart WA (1980) Implications of very high serum prolactin levels associated with pituitary tumors. J Neurosurg 52: 226–228
Fahlbusch R, Buchfelder M, Werder K von (1984) Present status of surgical treatment of prolactinomas. In: Lamberts SWJ, Tilders FJH, Veen EA van der, Assies J (eds) Trends in diagnosis and treatment of pituitary adenomas. Free University Press, Amsterdam, pp 121–132
Pusey E, Kortman KE, Flannigan BD, Tsuruda J, Bradley WG (1987) MR of craniopharyngiomas: tumor delineation and characterization. AJNR 8: 439–444
Yousem DM, Arrington JA, Zinreich SJ, Kumar AJ, Bryan RN (1989) Pituitary adenomas: possible role of bromocriptine in intratumoral hemorrhage. Radiology 170: 239–243
Breger RK, Rimm AA, Fischer ME, Papke RA, Haughton VM (1989) T1 and T2 measurements on a 1.5-T commercial MR imager. Radiology 171: 273–276
Kjos BO, Ehman RL, Brant-Zawadzki M, Kelly WM, Norman D, Newton TH (1985) Reproducibility of relaxation times and spin density calculated from routine MR imaging sequences: clinical study of the CNS. AJNR 6: 271–276
Kjos BO, Ehman RL, Brant-Zawadzki M (1985) Reproducibility of T1 and T2 relaxation times calculated from routine MR imaging sequences: phantom study. AJNR 6: 277–283
Thuomas K-Å (1987) Aspects of image intensity and relaxation time assessment in magnetic resonance imaging. Almqvist & Wiksell, Uppsala, pp 20–24
Karnaze MG, Sartor K, Winthrop JD, Gado MH, Hodges FJ (1986) Suprasellar lesions: evaluation with MR imaging. Radiology 161: 77–82
Mikhael MA, Ciric IS (1988) MR imaging of pituitary tumors before and after surgical and/or medical treatment. J Comput Assist Tomogr 12: 441–445
Fink U, Bauer WM, Hartmann N, Oeckler R, Bise K, Werder K von, Engelhardt D (1988) Efficacy of MRI in patients with pituitary adenomas. In: Landolt AM, Heitz PU, Zapf J, Girard J, Del Pozo E (eds) Advances in pituitary adenoma research. Pergamon Press, Oxford, pp 131–134
Saeger W, Kant P, Caselitz J, Lüdecke DK (1988) Electron microscopical morphometry of pituitary adenomas. Comparison of tumours in acromegaly and hyperprolactinemia. Pathol Res Pract 183: 17–24
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lundin, P., Nyman, R., Burman, P. et al. MRI of pituitary macroadenomas with reference to hormonal activity. Neuroradiology 34, 43–51 (1992). https://doi.org/10.1007/BF00588432
Issue Date:
DOI: https://doi.org/10.1007/BF00588432